OBJECTIVE: To study the effect on mammographic breast density of two different continuous combined regimens for hormone therapy. DESIGN: Randomized clinical study. SETTING: University hospital. PATIENT(S): Postmenopausal women without an…
Studies have been undertaken to investigate the modulatory effects of a combination of 30 μg ethinylestradiol and 2.00 mg dienogest (Valette®) on ovarian function and on the hemostatic system. Modulation of ovarian function was investigated…
Forty healthy female volunteers aged between 19 and 35 years (27.3 +/- 4.1 years) with normal menstrual cycles were included in a double-blind, randomized, placebo-controlled study to investigate the influence on the hemostatic system of an…
Twenty-two healthy female volunteers with normal ovulatory cycles, aged between 20 and 34 years (27.3 +/- 4.1), were included in a single-center, noncomparative study to investigate the modulation of ovarian function by an oral contraceptiv…
Vergleichende Untersuchungen zum Einfluß von Ethinylestradiol-haltigen Kontrazeptiva mit Dienogest- oder Levonorgestrel-Komponente auf die Cytochrom P-450-Funktion in vivo was published in Dienogest on page 149.
Vergleichende Untersuchungen zum Einfluß von Ethinylestradiol-haltigen Kontrazeptiva mit Dienogest- oder Levonorgestrel-Komponente auf die Cytochrom P-450-Funktion in vivo was published in Dienogest on page 149.